Literature DB >> 3373705

Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.

R R Williams1, S C Hunt, P N Hopkins, B M Stults, L L Wu, S J Hasstedt, G K Barlow, S H Stephenson, J M Lalouel, H Kuida.   

Abstract

Population-based sibships with essential hypertension diagnosed before the age of 60 years are being screened in Utah to find two or more hypertensive siblings with the same biochemical abnormality as a clue to an inherited cause for their specific type of hypertension. Among 131 hypertensive subjects in 58 sibships, concordant abnormalities in fasting serum lipid concentrations were observed in two or more siblings in 48% of the sibships. After adjusting for effects of antihypertensive medications, abnormal values reported in only 10% of the Lipid Research Clinics data were observed in 30% of patients for serum triglycerides, 19% for serum low-density lipoprotein cholesterol, and 39% for high-density lipoprotein cholesterol. More than one lipid level was abnormal in almost all concordant sibships, suggesting an association between hypertension and a syndrome of mixed lipid abnormalities, probably familial combined hyperlipidemia (renamed "familial combined dyslipidemia" because of common low high-density lipoprotein cholesterol levels). We conclude that familial dyslipidemic hypertension may be a specific syndrome with lipid abnormalities more severe than blood pressure elevations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373705     DOI: 10.1001/jama.259.24.3579

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

Review 1.  Nonesterified fatty acids in blood pressure control and cardiovascular complications.

Authors:  B M Egan; E L Greene; T L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Hypercholesterolemia and Dyslipidemia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

3.  Preventive medicine in primary care: management of hyperlipidaemia.

Authors:  B Lewis
Journal:  Br J Gen Pract       Date:  1992-02       Impact factor: 5.386

4.  Quantitative trait loci influencing cholesterol and phospholipid phenotypes map to chromosomes that contain genes regulating blood pressure in the spontaneously hypertensive rat.

Authors:  A Bottger; H A van Lith; V Kren; D Krenová; V Bílá; J Vorlícek; V Zídek; A Musilová; M Zdobinská; J M Wang; B F van Zutphen; T W Kurtz; M Pravenec
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia.

Authors:  France Gagnon; Gail P Jarvik; Michael D Badzioch; Arno G Motulsky; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2005-06-16       Impact factor: 4.132

Review 6.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

Review 7.  Apolipoproteins and metabolism in atherosclerosis.

Authors:  A M Gotto
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

8.  Linkage analysis incorporating gene-age interactions identifies seven novel lipid loci: the Family Blood Pressure Program.

Authors:  Jeannette Simino; Rezart Kume; Aldi T Kraja; Stephen T Turner; Craig L Hanis; Wayne Sheu; Ida Chen; Cashell Jaquish; Richard S Cooper; Aravinda Chakravarti; Thomas Quertermous; Eric Boerwinkle; Steven C Hunt; D C Rao
Journal:  Atherosclerosis       Date:  2014-04-26       Impact factor: 5.162

9.  Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota.

Authors:  M Fornage; S T Turner; C F Sing; E Boerwinkle
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

10.  Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?

Authors:  D Giugliano; A Quatraro; A Minei; N De Rosa; L Coppola; F D'Onofrio
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.